Cyclodextrin-mediated crystallization of acid β-glucosidase in complex with amphiphilic bicyclic nojirimycin analogues (Q27667205)

5

0 references

Matilde Aguilar-Moncayo

Matilde Aguilar-Moncayo

2

0 references

Juan M. Benito

Juan M Benito

3

0 references

Joel L. Sussman

Joel L Sussman

8

0 references

Anthony H. Futerman

Anthony H Futerman

9

0 references

Carmen Ortiz Mellet

Carmen Ortiz Mellet

José Manuel García Fernández

10

0 references

José M García Fernandez

4

0 references

author name string

Boris Brumshtein

1

0 references

Yoseph Shaaltiel

6

0 references

David Aviezer

Organic and Biomolecular Chemistry

7

0 references

publication date

7 June 2011

0 references

published in

0 references

volume

9

0 references

issue

11

0 references

page(s)

4160-7

0 references

cites work

The biogenesis of lysosomes

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Lysosomal disorders: from storage to cellular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

The cell biology of lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Enzyme therapy for Gaucher disease: the first 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Therapeutic strategies to ameliorate lysosomal storage disorders--a focus on Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Enzyme replacement for lysosomal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Imiglucerase and its use for the treatment of Gaucher's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Substrate reduction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Pharmacologic chaperoning as a strategy to treat Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-beta-glucosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Pharmacological chaperone therapy for Gaucher disease: a patent review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Click chemistry approach to new N-substituted aminocyclitols as potential pharmacological chaperones for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on beta-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Castanospermine-trehazolin hybrids: a new family of glycomimetics with tuneable glycosidase inhibitory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Synthesis and evaluation of isourea-type glycomimetics related to the indolizidine and trehazolin glycosidase inhibitor families

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Synthesis of N-, S-, and C-glycoside castanospermine analogues with selective neutral alpha-glucosidase inhibitory activity as antitumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

A Fluorescent sp2-iminosugar with pharmacological chaperone activity for gaucher disease: synthesis and intracellular distribution studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Fluorescent-tagged sp2-iminosugars with potent β-glucosidase inhibitory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Molecular basis for beta-glucosidase inhibition by ring-modified calystegine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Glycosidase inhibition by ring-modified castanospermine analogues: tackling enzyme selectivity by inhibitor tailoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

6-Amino-6-deoxy-5,6-di-N-(N'-octyliminomethylidene)nojirimycin: synthesis, biological evaluation, and crystal structure in complex with acid beta-glucosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

X-ray structure of human acid-β-glucosidase, the defective enzyme in Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Characterization of gene-activated human acid- -glucosidase: Crystal structure, glycan composition, and internalization into macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Acid beta-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

A pedestrian guide to membrane protein crystallization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

The role of protein and surfactant interactions in membrane-protein crystallization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Simple Host−Guest Chemistry To Modulate the Process of Concentration and Crystallization of Membrane Proteins by Detergent Capture in a Microfluidic Device

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Synthesis of thiohydantoin-castanospermine glycomimetics as glycosidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Processing of X-ray diffraction data collected in oscillation mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Refinement of macromolecular structures by the maximum-likelihood method

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

Features and development of Coot

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05200D